<?xml version='1.0' encoding='UTF-8'?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://viralgen.com/resources/leveraging-historical-data-and-percentile-based-modeling-for-improved-aav-production-scaling</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2025-07-23</lastmod></url><url><loc>https://viralgen.com/resources/navigating-variability-and-scalability-challenges-in-aav-production</loc><lastmod>2025-03-14</lastmod></url><url><loc>https://viralgen.com/insights/inversiones-para-la-creacion-de-un-nuevo-laboratorio-de-control-de-calidad-askbio-center-of-excellence-ace</loc><lastmod>2024-09-27</lastmod></url><url><loc>https://viralgen.com/news/viralgen-partners-vallabh-minikel-deverman-lab-broad-institute-gene-therapy-prion-disease</loc><lastmod>2025-01-21</lastmod></url><url><loc>https://viralgen.com/resources/displacement-chromatography-for-enrichment-of-raav-genome-containing-capsids-using-weak-organic-acid</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2024-11-22</lastmod></url><url><loc>https://viralgen.com/insights/viralgen-vector-core-and-elpida-therapeutics-partner-to-manufacture-gene-therapy-medicines-for-anticipated-spastic-paraplegia-50-spg50-and-charcot-marie-tooth-disease</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2024-11-22</lastmod></url><url><loc>https://viralgen.com/news/askbio-announces-6-presentations-at-the-european-society-of-gene-and-cell-therapy-32nd-annual-meeting</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/ESGCT%20AskBio%20PR%20Featured%20Image.png</image:loc><image:caption>ESGCT AskBio PR Featured Image</image:caption><image:title>ESGCT AskBio PR Featured Image</image:title></image:image><lastmod>2025-10-02</lastmod></url><url><loc>https://viralgen.com/news/the-basque-national-orchestra-debutes-in-poland-with-a-tour-of-four-concerts</loc><lastmod>2024-11-22</lastmod></url><url><loc>https://viralgen.com/legal-notice-terms-of-use</loc><lastmod>2026-08-21</lastmod></url><url><loc>https://viralgen.com/resources/addressing-the-complex-regulatory-environment-for-gene-therapies</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2025-01-17</lastmod></url><url><loc>https://viralgen.com/sustainability-policy</loc><lastmod>2025-07-31</lastmod></url><url><loc>https://viralgen.com/news/viralgen-inaugurates-its-new-msat-laboratory-in-donostia</loc><lastmod>2024-09-26</lastmod></url><url><loc>https://viralgen.com/resources/breaking-through-the-challenges-of-raav-purity-characterization-by-ce-sds</loc><lastmod>2024-11-18</lastmod></url><url><loc>https://viralgen.com/information-security-policy</loc><lastmod>2025-07-31</lastmod></url><url><loc>https://viralgen.com/resources/accelerating-gene-therapy-commercialization-through-structured-data</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Pdf%20thumbnail%20%20From%20Platform%20Promise%20To%20Commercial%20Reality%20Accelerating%20Gene%20Therapy%20Commercialization%20Through%20Structure%20(1).png</image:loc><image:caption>Pdf thumbnail  From Platform Promise To Commercial Reality Accelerating Gene Therapy Commercialization Through Structure (1)</image:caption><image:title>Pdf thumbnail  From Platform Promise To Commercial Reality Accelerating Gene Therapy Commercialization Through Structure (1)</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/ddPCR-Based%20Quantification%20and%20Fragment%20Analysis%20of%20Residual%20E1A%20in%20rAAV%20Products_%20Method%20Validation%20and%20Correlation%20with%20Total%20Host%20Cell%20DNA.png</image:loc><image:caption>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:caption><image:title>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><lastmod>2026-08-19</lastmod></url><url><loc>https://viralgen.com/privacy-policy</loc><lastmod>2026-08-19</lastmod></url><url><loc>https://viralgen.com/insights/rare-disease-day-2026</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20RDD%202026%20Blog%20Featured%20Image.png</image:loc><image:caption>VRLG RDD 2026 Blog Featured Image</image:caption><image:title>VRLG RDD 2026 Blog Featured Image</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/PXL_20260227_114129669.jpeg</image:loc><image:caption>PXL_20260227_114129669</image:caption><image:title>PXL_20260227_114129669</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/PXL_20260227_140911669.PORTRAIT.jpeg</image:loc><image:caption>PXL_20260227_140911669.PORTRAIT</image:caption><image:title>PXL_20260227_140911669.PORTRAIT</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/PXL_20260227_100401277.jpeg</image:loc><image:caption>PXL_20260227_100401277</image:caption><image:title>PXL_20260227_100401277</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/PXL_20260227_084423778.PORTRAIT.jpeg</image:loc><image:caption>PXL_20260227_084423778.PORTRAIT</image:caption><image:title>PXL_20260227_084423778.PORTRAIT</image:title></image:image><lastmod>2026-03-30</lastmod></url><url><loc>https://viralgen.com/es/insights/la-ia-como-catalizador-para-transformar-vidas-permitiendo-un-desarrollo-y-fabricacion-de-terapias-genicas-mas-veloz-y-eficaz</loc><lastmod>2025-07-28</lastmod></url><url><loc>https://viralgen.com/resources/multivariate-approach-to-ssmq-in-upstream-aav-production</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Multivariate%20Approach%20to%20small-scale%20Model%20Qualification%20(SSMQ)%20in%20Upstream%20(USP)%20Adeno-Associated%20Virus%20(AAV)%20Production-1.png</image:loc><image:caption>Multivariate Approach to small-scale Model Qualification (SSMQ) in Upstream (USP) Adeno-Associated Virus (AAV) Production-1</image:caption><image:title>Multivariate Approach to small-scale Model Qualification (SSMQ) in Upstream (USP) Adeno-Associated Virus (AAV) Production-1</image:title></image:image><lastmod>2026-06-01</lastmod></url><url><loc>https://viralgen.com/news/susana-solis-perez-member-of-european-parliament-visited-viralgen</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2024-11-22</lastmod></url><url><loc>https://viralgen.com/news/viralgen-joins-orphan-therapeutics-accelerator-clinical-development-network-as-a-manufacturing-partner-to-advance-rare-disease-therapies</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2025-05-14</lastmod></url><url><loc>https://viralgen.com/insights</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpg</video:thumbnail_loc><video:title>Life Science In Action VIRALGEN 11_12 v3</video:title><video:description>Life Science In Action VIRALGEN 11_12 v3</video:description><video:content_loc>https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4</video:content_loc><video:duration>120</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Video_2026_OPCU_v2.gif</image:loc><image:caption>VRLG Video_2026_OPCU_v2</image:caption><image:title>VRLG Video_2026_OPCU_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20ASGCT%202026_post%20event%20blog_1200x627_v1.gif</image:loc><image:caption>VRLG ASGCT 2026_post event blog_1200x627_v1</image:caption><image:title>VRLG ASGCT 2026_post event blog_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG_2025%20Conference%20Recap_v1.gif</image:loc><image:caption>VRLG_2025 Conference Recap_v1</image:caption><image:title>VRLG_2025 Conference Recap_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_Visit%20from%20Donostia%20Mayor_v1.gif</image:loc><image:caption>VRLG blog_2026_Visit from Donostia Mayor_v1</image:caption><image:title>VRLG blog_2026_Visit from Donostia Mayor_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG_XTalks%20Webinar%20Summary_thumbnail_v1.gif</image:loc><image:caption>VRLG_XTalks Webinar Summary_thumbnail_v1</image:caption><image:title>VRLG_XTalks Webinar Summary_thumbnail_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gif</image:loc><image:caption>Viralgen Science In Action blog_opt1_V1</image:caption><image:title>Viralgen Science In Action blog_opt1_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20RDD%202026%20Blog%20Featured%20Image.png</image:loc><image:caption>VRLG RDD 2026 Blog Featured Image</image:caption><image:title>VRLG RDD 2026 Blog Featured Image</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_El%20Diario%20Vasco%20Sustainability%20Interview_v1.2.gif</image:loc><image:caption>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:caption><image:title>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:title></image:image><lastmod>2025-01-24</lastmod></url><url><loc>https://viralgen.com/what-we-do</loc><image:image><image:loc>https://viralgen.com/hubfs/Other-manufacturers-X.svg</image:loc><image:caption>Other-manufacturers-X</image:caption><image:title>Other-manufacturers-X</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Geo%20texture%20light%202%201.png</image:loc><image:caption>Geo texture light 2 1</image:caption><image:title>Geo texture light 2 1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Group%20114.png</image:loc><image:caption>Group 114</image:caption><image:title>Group 114</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2026-05-13</lastmod></url><url><loc>https://viralgen.com/insights/viralgen-vector-core-s-l-leading-a-joint-effort-in-revolutionary-gene-therapy-advancements</loc><image:image><image:loc>https://viralgen.com/hubfs/Cofinanciado%20por%20la%20UE.png</image:loc><image:caption>Cofinanciado por la UE</image:caption><image:title>Cofinanciado por la UE</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Gob%20Vasco.png</image:loc><image:caption>Gob Vasco</image:caption><image:title>Gob Vasco</image:title></image:image><lastmod>2026-04-30</lastmod></url><url><loc>https://viralgen.com/resources/unlocking-efficiency-in-aav-manufacturing-with-doe-insights</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2025-01-17</lastmod></url><url><loc>https://viralgen.com/offline</loc><lastmod>2026-05-27</lastmod></url><url><loc>https://viralgen.com/insights/rare-disease-day-2025</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2026-01-23</lastmod></url><url><loc>https://viralgen.com/news/viralgen-welcomes-the-visit-of-alberto-nunez-feijoo-president-of-spain-s-partido-popular</loc><lastmod>2024-09-26</lastmod></url><url><loc>https://viralgen.com/resources/comparing-ultracentrifugation-versus-aex-for-successful-aav-purification</loc><lastmod>2025-03-14</lastmod></url><url><loc>https://viralgen.com/cookies-policy</loc><lastmod>2026-08-19</lastmod></url><url><loc>https://viralgen.com/resources/taav-and-viralgen-together-as-your-raav-manufacturing-solution</loc><lastmod>2024-10-22</lastmod></url><url><loc>https://viralgen.com/resources/enhancing-aav6-vector-production-for-cell-therapies</loc><lastmod>2024-10-16</lastmod></url><url><loc>https://viralgen.com/resources/white-paper-a-proprietary-mammalian-suspension-technology-for-scalable-raav-production-the-pro10-cell-line</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2025-03-14</lastmod></url><url><loc>https://viralgen.com/resources/boosting-aav-manufacturing-performance-with-multivariate-data-analysis</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><lastmod>2025-01-17</lastmod></url><url><loc>https://viralgen.com/news/epilepsygtx-and-viralgen-collaborate-to-advance-aav-gene-therapy-programme-for-epilepsy-ahead-of-first-in-human-trial</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Elaaj%20Bio%20Press%20Release%202026_V1.gif</image:loc><image:caption>VRLG Elaaj Bio Press Release 2026_V1</image:caption><image:title>VRLG Elaaj Bio Press Release 2026_V1</image:title></image:image><lastmod>2026-09-09</lastmod></url><url><loc>https://viralgen.com/es/insights</loc><lastmod>2025-01-31</lastmod></url><url><loc>https://viralgen.com/news/viralgen-elaaj-bio-to-advance-gene-therapy</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Elaaj%20Bio%20Press%20Release%202026_V1.gif</image:loc><image:caption>VRLG Elaaj Bio Press Release 2026_V1</image:caption><image:title>VRLG Elaaj Bio Press Release 2026_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2026-05-05</lastmod></url><url><loc>https://viralgen.com/process-development</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2026-05-19</lastmod></url><url><loc>https://viralgen.com/late-phase-production</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2026-05-19</lastmod></url><url><loc>https://viralgen.com/resources/webinar-making-a-meaningful-impact-in-aav</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpg</video:thumbnail_loc><video:title>Andy Holt @ MOTM 2025</video:title><video:description>Andy Holt @ MOTM 2025</video:description><video:content_loc>https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4</video:content_loc><video:duration>849</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gif</image:loc><image:caption>VRLG_MotM 2025 Webinar_1200x627_v1</image:caption><image:title>VRLG_MotM 2025 Webinar_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2025-11-03</lastmod></url><url><loc>https://viralgen.com/resources/addressing-manufacturing-and-characterization-challenges-and-opportunities-with-novel-aav-capsids</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/ddPCR-Based%20Quantification%20and%20Fragment%20Analysis%20of%20Residual%20E1A%20in%20rAAV%20Products_%20Method%20Validation%20and%20Correlation%20with%20Total%20Host%20Cell%20DNA.png</image:loc><image:caption>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:caption><image:title>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:title></image:image><lastmod>2026-06-08</lastmod></url><url><loc>https://viralgen.com/resources/ddpcr-based-quantification-and-fragment-analysis-of-residual-e1a-in-raav-products-method-validation-and-correlation-with-total-host-cell-dna</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/ddPCR-Based%20Quantification%20and%20Fragment%20Analysis%20of%20Residual%20E1A%20in%20rAAV%20Products_%20Method%20Validation%20and%20Correlation%20with%20Total%20Host%20Cell%20DNA.png</image:loc><image:caption>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:caption><image:title>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:title></image:image><lastmod>2026-06-01</lastmod></url><url><loc>https://viralgen.com/resources/integrating-raman-spectroscopy-and-genome-scale-modeling-to-enhance-aav-upstream-manufacturing</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2025-07-23</lastmod></url><url><loc>https://viralgen.com/resources/facing-the-dual-scientific-and-financial-challenges-to-advance-cell-and-gene-therapies</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2025-03-14</lastmod></url><url><loc>https://viralgen.com/insights/inversiones-para-la-creacion-de-un-nuevo-servicio-de-caracterizacion-de-proceso-de-fabricacion-industrial-de-vectores-virales-aav-msat</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20RDD%202026%20Blog%20Featured%20Image.png</image:loc><image:caption>VRLG RDD 2026 Blog Featured Image</image:caption><image:title>VRLG RDD 2026 Blog Featured Image</image:title></image:image><lastmod>2024-09-26</lastmod></url><url><loc>https://viralgen.com/resources/nedna-is-a-robust-alternative-to-plasmid-dna-for-aav-production</loc><lastmod>2024-10-16</lastmod></url><url><loc>https://viralgen.com/news/viralgen-and-ctnnb1-foundation-partner-to-manufacture-a-new-gene-therapy-for-ctnnb1-syndrome</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2025-07-31</lastmod></url><url><loc>https://viralgen.com/news/viralgen-announces-planned-ceo-succession</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_AskBio%20Press%20Release_v1.gif</image:loc><image:caption>VRLG PR_2026_AskBio Press Release_v1</image:caption><image:title>VRLG PR_2026_AskBio Press Release_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20press%20release_CEO%20Announcement%20Blog_V1.gif</image:loc><image:caption>VRLG press release_CEO Announcement Blog_V1</image:caption><image:title>VRLG press release_CEO Announcement Blog_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2026-10-19</lastmod></url><url><loc>https://viralgen.com/resources/overcoming-variability-and-scaling-challenges-in-aav-manufacturing</loc><lastmod>2025-03-14</lastmod></url><url><loc>https://viralgen.com/insights/viralgen-asgct-what-we-saw-what-to-keep-an-eye-on</loc><image:image><image:loc>https://viralgen.com/hubfs/20260513_123754.jpg</image:loc><image:caption>20260513_123754</image:caption><image:title>20260513_123754</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20ASGCT%202026_post%20event%20blog_1200x627_v1.gif</image:loc><image:caption>VRLG ASGCT 2026_post event blog_1200x627_v1</image:caption><image:title>VRLG ASGCT 2026_post event blog_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/20260514_154037.jpg</image:loc><image:caption>20260514_154037</image:caption><image:title>20260514_154037</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2026-06-01</lastmod></url><url><loc>https://viralgen.com/manufacturing-platforms</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Manufacturing-platforms_chart_V2.svg</image:loc><image:caption>Manufacturing-platforms_chart_V2</image:caption><image:title>Manufacturing-platforms_chart_V2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Triple-Plasmid%20Transfection.png</image:loc><image:caption>Triple-Plasmid Transfection</image:caption><image:title>Triple-Plasmid Transfection</image:title></image:image><lastmod>2025-10-07</lastmod></url><url><loc>https://viralgen.com/resources/industry-takeaways-from-fdas-cell-and-gene-therapy-listening-session</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg</video:thumbnail_loc><video:title>10760_20251020115848541_gen_17thoct_1400et_od</video:title><video:description>10760_20251020115848541_gen_17thoct_1400et_od</video:description><video:content_loc>https://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4</video:content_loc><video:duration>3256</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/GEN%20Webinar%20Panelists.svg</image:loc><image:caption>GEN Webinar Panelists</image:caption><image:title>GEN Webinar Panelists</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).png</image:loc><image:caption>VRLG GEN Webinar Oct 2025 Feature Image (1)</image:caption><image:title>VRLG GEN Webinar Oct 2025 Feature Image (1)</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><lastmod>2025-10-24</lastmod></url><url><loc>https://viralgen.com/insights/successful-meeting-at-the-asgct-2023</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2024-11-22</lastmod></url><url><loc>https://viralgen.com/insights/video-outsourced-pharma-capacity-update-2026</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Viralgen%20For%20AP-esv2-85p-bg-10p-music-10p.mp4/medium.jpg</video:thumbnail_loc><video:title>Outsourced Pharma Capacity Update 2026</video:title><video:description>Viralgen For AP-esv2-85p-bg-10p-music-10p</video:description><video:content_loc>https://viralgen.com/hubfs/Viralgen%20For%20AP-esv2-85p-bg-10p-music-10p.mp4</video:content_loc><video:duration>1102</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Video_2026_OPCU_v2.gif</image:loc><image:caption>VRLG Video_2026_OPCU_v2</image:caption><image:title>VRLG Video_2026_OPCU_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20press%20release_CEO%20Announcement%20Blog_V1.gif</image:loc><image:caption>VRLG press release_CEO Announcement Blog_V1</image:caption><image:title>VRLG press release_CEO Announcement Blog_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2026-10-13</lastmod></url><url><loc>https://viralgen.com/es/insights/transformaci%C3%B3n-digital-en-viralgen</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2025-01-31</lastmod></url><url><loc>https://viralgen.com/news/viralgen-collaborates-with-trogenix-to-advance-aav-gene-therapy-for-gliobastoma</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2025-05-06</lastmod></url><url><loc>https://viralgen.com/insights/visit-us-at-phacilitate-advanced-therapies-week-in-miami</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG_2025%20Conference%20Recap_v1.gif</image:loc><image:caption>VRLG_2025 Conference Recap_v1</image:caption><image:title>VRLG_2025 Conference Recap_v1</image:title></image:image><lastmod>2024-09-27</lastmod></url><url><loc>https://viralgen.com/news/javier-garcia-receives-the-tambor-de-oro-2023</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://viralgen.com/news/askbio-announces-6-presentations-at-american-society-of-gene-and-cell-therapy-asgct-29th-annual-meeting</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Elaaj%20Bio%20Press%20Release%202026_V1.gif</image:loc><image:caption>VRLG Elaaj Bio Press Release 2026_V1</image:caption><image:title>VRLG Elaaj Bio Press Release 2026_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><lastmod>2026-05-07</lastmod></url><url><loc>https://viralgen.com/insights/harnessing-ai-for-faster-and-more-efficient-development-manufacturing-of-life-changing-gene-therapies</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_Visit%20from%20Donostia%20Mayor_v1.gif</image:loc><image:caption>VRLG blog_2026_Visit from Donostia Mayor_v1</image:caption><image:title>VRLG blog_2026_Visit from Donostia Mayor_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_El%20Diario%20Vasco%20Sustainability%20Interview_v1.2.gif</image:loc><image:caption>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:caption><image:title>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20ASGCT%202026_post%20event%20blog_1200x627_v1.gif</image:loc><image:caption>VRLG ASGCT 2026_post event blog_1200x627_v1</image:caption><image:title>VRLG ASGCT 2026_post event blog_1200x627_v1</image:title></image:image><lastmod>2025-07-28</lastmod></url><url><loc>https://viralgen.com/resources/digital-standardization-accelerating-gene-therapy-tech-transfer-with-confidence-and-compliance</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/LSC%20Whitepaper_scientist.png</image:loc><image:caption>LSC Whitepaper_scientist</image:caption><image:title>LSC Whitepaper_scientist</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2026-05-11</lastmod></url><url><loc>https://viralgen.com/resources/enhancing-cmc-regulatory-efficiency-in-gene-therapy</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://viralgen.com/news</loc><image:image><image:loc>https://viralgen.com/hubfs/AskBios%20Viralgen%20to%20Supply%20Commercial-Scale%20Drug%20Product%20for%20REGENERATE-PD%20Investigational%20Gene%20Therapy%20Phase%20II%20Trial%20for%20Parkinson%E2%80%99s%20Disease.gif</image:loc><image:caption>AskBios Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease</image:caption><image:title>AskBios Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_AskBio%20Press%20Release_v1.gif</image:loc><image:caption>VRLG PR_2026_AskBio Press Release_v1</image:caption><image:title>VRLG PR_2026_AskBio Press Release_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20press%20release_CEO%20Announcement%20Blog_V1.gif</image:loc><image:caption>VRLG press release_CEO Announcement Blog_V1</image:caption><image:title>VRLG press release_CEO Announcement Blog_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gif</image:loc><image:caption>VRLG Apertura Press Release_1200x627_v1.1</image:caption><image:title>VRLG Apertura Press Release_1200x627_v1.1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/ESGCT%20AskBio%20PR%20Featured%20Image.png</image:loc><image:caption>ESGCT AskBio PR Featured Image</image:caption><image:title>ESGCT AskBio PR Featured Image</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Elaaj%20Bio%20Press%20Release%202026_V1.gif</image:loc><image:caption>VRLG Elaaj Bio Press Release 2026_V1</image:caption><image:title>VRLG Elaaj Bio Press Release 2026_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2025-01-24</lastmod></url><url><loc>https://viralgen.com/insights/advanced-therapies-conference-recap-key-takeaways-from-key-cgt-fall-conferences</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://viralgen.com/insights/webinar-from-platform-knowledge-to-commercial-readiness</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/FINAL%20From%20Platform%20Knowledge%20to%20Commercial%20Readiness%20Accelerating%20and%20De-risking%20your%20AAV%20Therapy%E2%80%99s%20Path%20to%20Patients.mp4/medium.jpg</video:thumbnail_loc><video:title>FINAL From Platform Knowledge to Commercial Readiness Accelerating and De-risking your AAV Therapy’s Path to Patients</video:title><video:description>FINAL From Platform Knowledge to Commercial Readiness Accelerating and De-risking your AAV Therapy’s Path to Patients</video:description><video:content_loc>https://viralgen.com/hubfs/FINAL%20From%20Platform%20Knowledge%20to%20Commercial%20Readiness%20Accelerating%20and%20De-risking%20your%20AAV%20Therapy%E2%80%99s%20Path%20to%20Patients.mp4</video:content_loc><video:duration>3502</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Viralgen%20For%20AP-esv2-85p-bg-10p-music-10p.mp4/medium.jpg</video:thumbnail_loc><video:title>Outsourced Pharma Capacity Update 2026</video:title><video:description>Viralgen For AP-esv2-85p-bg-10p-music-10p</video:description><video:content_loc>https://viralgen.com/hubfs/Viralgen%20For%20AP-esv2-85p-bg-10p-music-10p.mp4</video:content_loc><video:duration>1102</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/VRLG_XTalks%20Webinar%20Summary_thumbnail_v1.gif</image:loc><image:caption>VRLG_XTalks Webinar Summary_thumbnail_v1</image:caption><image:title>VRLG_XTalks Webinar Summary_thumbnail_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_AskBio%20Press%20Release_v1.gif</image:loc><image:caption>VRLG PR_2026_AskBio Press Release_v1</image:caption><image:title>VRLG PR_2026_AskBio Press Release_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Video_2026_OPCU_v2.gif</image:loc><image:caption>VRLG Video_2026_OPCU_v2</image:caption><image:title>VRLG Video_2026_OPCU_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20press%20release_CEO%20Announcement%20Blog_V1.gif</image:loc><image:caption>VRLG press release_CEO Announcement Blog_V1</image:caption><image:title>VRLG press release_CEO Announcement Blog_V1</image:title></image:image><lastmod>2026-10-26</lastmod></url><url><loc>https://viralgen.com/insights/science-in-action</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpg</video:thumbnail_loc><video:title>Life Science In Action VIRALGEN 11_12 v3</video:title><video:description>Life Science In Action VIRALGEN 11_12 v3</video:description><video:content_loc>https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4</video:content_loc><video:duration>120</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gif</image:loc><image:caption>Viralgen Science In Action blog_opt1_V1</image:caption><image:title>Viralgen Science In Action blog_opt1_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_El%20Diario%20Vasco%20Sustainability%20Interview_v1.2.gif</image:loc><image:caption>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:caption><image:title>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_Visit%20from%20Donostia%20Mayor_v1.gif</image:loc><image:caption>VRLG blog_2026_Visit from Donostia Mayor_v1</image:caption><image:title>VRLG blog_2026_Visit from Donostia Mayor_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20ASGCT%202026_post%20event%20blog_1200x627_v1.gif</image:loc><image:caption>VRLG ASGCT 2026_post event blog_1200x627_v1</image:caption><image:title>VRLG ASGCT 2026_post event blog_1200x627_v1</image:title></image:image><lastmod>2026-01-28</lastmod></url><url><loc>https://viralgen.com/resources/working-with-regulators-to-get-gene-therapies-to-more-patients</loc><lastmod>2024-10-16</lastmod></url><url><loc>https://viralgen.com/resources/streamlining-advanced-therapy-medicinal-product-manufacturing-a-platform-approach-for-accelerating-gene-therapy-commercialization</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Screenshot%202024-09-24%20at%2010.28.29%20AM%201.png</image:loc><image:caption>Screenshot 2024-09-24 at 10.28.29 AM 1</image:caption><image:title>Screenshot 2024-09-24 at 10.28.29 AM 1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><lastmod>2025-10-03</lastmod></url><url><loc>https://viralgen.com/news/gene2cure-foundation-and-viralgen-collaborate-to-advance-a-portfolio-of-gene-therapy-programs-for-rare-and-ultra-rare-genetic-conditions</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20press%20release_Gene2Cure%20Foundation_V1.png</image:loc><image:caption>VRLG press release_Gene2Cure Foundation_V1</image:caption><image:title>VRLG press release_Gene2Cure Foundation_V1</image:title></image:image><lastmod>2026-11-17</lastmod></url><url><loc>https://viralgen.com/insights/viralgen-at-the-asgct-26th-annual-meeting</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG_2025%20Conference%20Recap_v1.gif</image:loc><image:caption>VRLG_2025 Conference Recap_v1</image:caption><image:title>VRLG_2025 Conference Recap_v1</image:title></image:image><lastmod>2024-09-30</lastmod></url><url><loc>https://viralgen.com/resources/exploring-key-regulatory-considerations-to-ensure-patient-safety-in-the-gene-therapy-space</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2025-07-09</lastmod></url><url><loc>https://viralgen.com/personal-data-protection</loc><lastmod>2025-07-31</lastmod></url><url><loc>https://viralgen.com/insights/reflections-on-inclusion-and-diversity-with-sonia-guirado-from-eurofirms-foundation</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2024-11-22</lastmod></url><url><loc>https://viralgen.com/resources/repeatability-and-intermediate-precision-of-a-genome-integrity-assay-for-raav-by-long-read-sequencing</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/ddPCR-Based%20Quantification%20and%20Fragment%20Analysis%20of%20Residual%20E1A%20in%20rAAV%20Products_%20Method%20Validation%20and%20Correlation%20with%20Total%20Host%20Cell%20DNA.png</image:loc><image:caption>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:caption><image:title>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2026-06-01</lastmod></url><url><loc>https://viralgen.com/news/askbio-announces-5-presentations-at-the-european-society-of-gene-and-cell-therapy-esgct-33rd-annual-congress</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_AskBio%20Press%20Release_v1.gif</image:loc><image:caption>VRLG PR_2026_AskBio Press Release_v1</image:caption><image:title>VRLG PR_2026_AskBio Press Release_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20press%20release_CEO%20Announcement%20Blog_V1.gif</image:loc><image:caption>VRLG press release_CEO Announcement Blog_V1</image:caption><image:title>VRLG press release_CEO Announcement Blog_V1</image:title></image:image><lastmod>2026-10-22</lastmod></url><url><loc>https://viralgen.com/insights/rare-disease-day-2023</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpg</video:thumbnail_loc><video:title>Life Science In Action VIRALGEN 11_12 v3</video:title><video:description>Life Science In Action VIRALGEN 11_12 v3</video:description><video:content_loc>https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4</video:content_loc><video:duration>120</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gif</image:loc><image:caption>Viralgen Science In Action blog_opt1_V1</image:caption><image:title>Viralgen Science In Action blog_opt1_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20RDD%202026%20Blog%20Featured%20Image.png</image:loc><image:caption>VRLG RDD 2026 Blog Featured Image</image:caption><image:title>VRLG RDD 2026 Blog Featured Image</image:title></image:image><lastmod>2024-09-27</lastmod></url><url><loc>https://viralgen.com/who-we-are</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Videos/VIRALGEN-ESGCT-LOOP-4K.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen: ALL-IN AAV</video:title><video:description>VIRALGEN-ESGCT-LOOP-4K</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Videos/VIRALGEN-ESGCT-LOOP-4K.mp4</video:content_loc><video:duration>106</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Who-we-are-section-shape-2-1.png</image:loc><image:caption>Who-we-are-section-shape-2-1</image:caption><image:title>Who-we-are-section-shape-2-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0009_Maria-Iglesias.png</image:loc><image:caption>Viralgen_2026__0009_Maria-Iglesias</image:caption><image:title>Viralgen_2026__0009_Maria-Iglesias</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Who-we-are-section-shape-gen26.png</image:loc><image:caption>Who-we-are-section-shape-gen26</image:caption><image:title>Who-we-are-section-shape-gen26</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0006_Daniel-Rivero.png</image:loc><image:caption>Viralgen_2026__0006_Daniel-Rivero</image:caption><image:title>Viralgen_2026__0006_Daniel-Rivero</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0000_Sarah-Smith.png</image:loc><image:caption>Viralgen_2026__0000_Sarah-Smith</image:caption><image:title>Viralgen_2026__0000_Sarah-Smith</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0010_Andy-Holt.png</image:loc><image:caption>Viralgen_2026__0010_Andy-Holt</image:caption><image:title>Viralgen_2026__0010_Andy-Holt</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Geo%20meeting_1-1.png</image:loc><image:caption>Geo meeting_1-1</image:caption><image:title>Geo meeting_1-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Who-we-are-section-shape-2.png</image:loc><image:caption>Who-we-are-section-shape-2</image:caption><image:title>Who-we-are-section-shape-2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0001_Marta-Labayan.png</image:loc><image:caption>Viralgen_2026__0001_Marta-Labayan</image:caption><image:title>Viralgen_2026__0001_Marta-Labayan</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Who-we-are-gem-shape-1-1.png</image:loc><image:caption>Who-we-are-gem-shape-1-1</image:caption><image:title>Who-we-are-gem-shape-1-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0003_Kontxi-San-Juam.png</image:loc><image:caption>Viralgen_2026__0003_Kontxi-San-Juam</image:caption><image:title>Viralgen_2026__0003_Kontxi-San-Juam</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0004_Jimmy-Vanhove.png</image:loc><image:caption>Viralgen_2026__0004_Jimmy-Vanhove</image:caption><image:title>Viralgen_2026__0004_Jimmy-Vanhove</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0005_Jacob-Smith.png</image:loc><image:caption>Viralgen_2026__0005_Jacob-Smith</image:caption><image:title>Viralgen_2026__0005_Jacob-Smith</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0008_Ana-Barbas.png</image:loc><image:caption>Viralgen_2026__0008_Ana-Barbas</image:caption><image:title>Viralgen_2026__0008_Ana-Barbas</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2026%20ELT%20Headshots/Viralgen_2026__0007_Cesar-Trigueros.png</image:loc><image:caption>Viralgen_2026__0007_Cesar-Trigueros</image:caption><image:title>Viralgen_2026__0007_Cesar-Trigueros</image:title></image:image><lastmod>2026-08-19</lastmod></url><url><loc>https://viralgen.com/resources/outsourced-pharma-capacity-update-july-2025</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Outsourced Pharma Capacity Update July 2025 - Fill/Finish</video:title><video:description>Don't miss Viralgen's presentation at Outsourced Pharma's Cell &amp;amp; Gene Therapy Capacity Update, where CCO Andy Holt unveiled an exciting initiative that will accelerate data acquisition for investor funding. Watch now us to discover how Viralgen drives industry progress through innovation and strategic support.</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp4</video:content_loc><video:duration>1235</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2025-09-24</lastmod></url><url><loc>https://viralgen.com/news/we-are-moving-towards-a-more-sustainable-future-with-solar-energy</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2024-11-22</lastmod></url><url><loc>https://viralgen.com/ai-policy</loc><lastmod>2026-03-17</lastmod></url><url><loc>https://viralgen.com/events</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Event%20Blogs/BIOSpain%202026%20Featured%20Image%20v1.3.gif</image:loc><image:caption>BIOSpain 2026 Featured Image v1.3</image:caption><image:title>BIOSpain 2026 Featured Image v1.3</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Event%20Blogs/Viralgen%202026%20events_MotM_V1.gif</image:loc><image:caption>Viralgen 2026 events_MotM_V1</image:caption><image:title>Viralgen 2026 events_MotM_V1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Event%20Blogs/ESGCT%202026%20Featured%20Image%20v1.4.gif</image:loc><image:caption>ESGCT 2026 Featured Image v1.4</image:caption><image:title>ESGCT 2026 Featured Image v1.4</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Event%20Blogs/Advanced%20Therpaies%20USA%20Featured%20Image%20v1.2.gif</image:loc><image:caption>Advanced Therpaies USA Featured Image v1.2</image:caption><image:title>Advanced Therpaies USA Featured Image v1.2</image:title></image:image><lastmod>2026-07-20</lastmod></url><url><loc>https://viralgen.com/resources/optimizing-scale-up-to-2000l-in-upstream-processing</loc><lastmod>2025-03-14</lastmod></url><url><loc>https://viralgen.com/resources/improving-scalability-and-productivity-of-transient-transfection-aav-production</loc><lastmod>2025-03-14</lastmod></url><url><loc>https://viralgen.com/news/viralgen-selected-as-manufacturing-engine-for-consortium-targeting-rare-childhood-diseases</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Elaaj%20Bio%20Press%20Release%202026_V1.gif</image:loc><image:caption>VRLG Elaaj Bio Press Release 2026_V1</image:caption><image:title>VRLG Elaaj Bio Press Release 2026_V1</image:title></image:image><lastmod>2026-07-28</lastmod></url><url><loc>https://viralgen.com</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Guido_V2.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen_Voices from the Field_Guido_V2</video:title><video:description>Viralgen_Voices from the Field_Guido_V2</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Guido_V2.mp4</video:content_loc><video:duration>47</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Viralgen_Voices%20from%20the%20Field_Ana%20Barbas_V2-1.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen_Voices from the Field_Ana Barbas_V2-1</video:title><video:description>Viralgen_Voices from the Field_Ana Barbas_V2-1</video:description><video:content_loc>https://viralgen.com/hubfs/Viralgen_Voices%20from%20the%20Field_Ana%20Barbas_V2-1.mp4</video:content_loc><video:duration>75</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Jimmy%20Vanhove_Q2_V1.2.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen_Voices from the Field_Jimmy Vanhove_Q2_V1.2</video:title><video:description>Viralgen_Voices from the Field_Jimmy Vanhove_Q2_V1.2</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Jimmy%20Vanhove_Q2_V1.2.mp4</video:content_loc><video:duration>49</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Maria%20Orio-2_V1.2.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen_Voices from the Field_Maria Orio-2_V1.2</video:title><video:description>Viralgen_Voices from the Field_Maria Orio-2_V1.2</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Maria%20Orio-2_V1.2.mp4</video:content_loc><video:duration>57</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Andy%20V2.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen_Voices from the Field_Andy V2</video:title><video:description>Viralgen_Voices from the Field_Andy V2</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Andy%20V2.mp4</video:content_loc><video:duration>85</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_C%C3%A9sar%20Trigueros_Q2_V2.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen_Voices from the Field_César Trigueros_Q2_V2</video:title><video:description>Viralgen_Voices from the Field_César Trigueros_Q2_V2</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_C%C3%A9sar%20Trigueros_Q2_V2.mp4</video:content_loc><video:duration>43</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_C%C3%A9sar%20Trigueros_Q1_V1.2.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen_Voices from the Field_César Trigueros_Q1_V1.2</video:title><video:description>Viralgen_Voices from the Field_César Trigueros_Q1_V1.2</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_C%C3%A9sar%20Trigueros_Q1_V1.2.mp4</video:content_loc><video:duration>33</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Jimmy%20Vanhove_Q1_V1.2.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen_Voices from the Field_Jimmy Vanhove_Q1_V1.2</video:title><video:description>Viralgen_Voices from the Field_Jimmy Vanhove_Q1_V1.2</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Jimmy%20Vanhove_Q1_V1.2.mp4</video:content_loc><video:duration>43</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Pooja_V2.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen_Voices from the Field_Pooja_V2</video:title><video:description>Viralgen_Voices from the Field_Pooja_V2</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Viralgen_Voices%20from%20the%20Field_Pooja_V2.mp4</video:content_loc><video:duration>38</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Viralgen%20Aava%20home%20page%20section_V1.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Aava home page section_V1</video:title><video:description>Viralgen Aava home page section_V1</video:description><video:content_loc>https://viralgen.com/hubfs/Viralgen%20Aava%20home%20page%20section_V1.mp4</video:content_loc><video:duration>1</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Viralgen%20Aava%20home%20page%20section_V1.webm/medium.jpg</video:thumbnail_loc><video:title>Viralgen Aava home page section_V1</video:title><video:description>Viralgen Aava home page section_V1</video:description><video:content_loc>https://viralgen.com/hubfs/Viralgen%20Aava%20home%20page%20section_V1.webm</video:content_loc><video:duration>1</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Videos/Viralgen-Video-Clip-optimized.mp4/medium.jpg</video:thumbnail_loc><video:title>Well-equipped to advance your gene therapy</video:title><video:description>Serving as the world’s manufacturing center of excellence for AAV demands all the right resources be right at hand. And at Viralgen, they are. That uniquely positions us to help our clients find a more direct path to commercialization based on our proven science, new-fashioned thinking, focused capacity, and a true-to-target track record.</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Videos/Viralgen-Video-Clip-optimized.mp4</video:content_loc><video:duration>13</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Home-gen26-section-shape-1.png</image:loc><image:caption>Home-gen26-section-shape-1</image:caption><image:title>Home-gen26-section-shape-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Maria_1.jpg</image:loc><image:caption>Maria_1</image:caption><image:title>Maria_1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Home-gen26-gem-mask-1.png</image:loc><image:caption>Home-gen26-gem-mask-1</image:caption><image:title>Home-gen26-gem-mask-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Rectangle%2037.png</image:loc><image:caption>Rectangle 37</image:caption><image:title>Rectangle 37</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Screenshot%202026-07-22%20at%202.57.30%20PM.png</image:loc><image:caption>Screenshot 2026-07-22 at 2.57.30 PM</image:caption><image:title>Screenshot 2026-07-22 at 2.57.30 PM</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Cesar_1.jpg</image:loc><image:caption>Cesar_1</image:caption><image:title>Cesar_1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Screenshot%202026-07-22%20at%202.58.57%20PM.png</image:loc><image:caption>Screenshot 2026-07-22 at 2.58.57 PM</image:caption><image:title>Screenshot 2026-07-22 at 2.58.57 PM</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Screenshot%202026-07-22%20at%202.57.15%20PM.png</image:loc><image:caption>Screenshot 2026-07-22 at 2.57.15 PM</image:caption><image:title>Screenshot 2026-07-22 at 2.57.15 PM</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Anna.jpg</image:loc><image:caption>Anna</image:caption><image:title>Anna</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Home-GEN26-aav-success-section-shape.png</image:loc><image:caption>Home-GEN26-aav-success-section-shape</image:caption><image:title>Home-GEN26-aav-success-section-shape</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Jimmy_1.jpg</image:loc><image:caption>Jimmy_1</image:caption><image:title>Jimmy_1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Home-gem-gen26.png</image:loc><image:caption>Home-gem-gen26</image:caption><image:title>Home-gem-gen26</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Voices%20From%20The%20Field/Jimmy_2.jpg</image:loc><image:caption>Jimmy_2</image:caption><image:title>Jimmy_2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/home_gem_3-2.png</image:loc><image:caption>home_gem_3-2</image:caption><image:title>home_gem_3-2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/lab-Icon-square.svg</image:loc><image:caption>lab-Icon-square</image:caption><image:title>lab-Icon-square</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Viralgen%202026%20Homepage%20FI.png</image:loc><image:caption>Viralgen 2026 Homepage FI</image:caption><image:title>Viralgen 2026 Homepage FI</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Viralgen_building-gem2-2-2.png</image:loc><image:caption>Viralgen_building-gem2-2-2</image:caption><image:title>Viralgen_building-gem2-2-2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Team-icon-square.svg</image:loc><image:caption>Team-icon-square</image:caption><image:title>Team-icon-square</image:title></image:image><lastmod>2026-09-16</lastmod></url><url><loc>https://viralgen.com/process</loc><lastmod>2026-05-19</lastmod></url><url><loc>https://viralgen.com/insights/viralgen-receives-cgmp-certification-to-produce-raav-commercial-grade-product-at-new-facility-in-san-sebastian-spain</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20RDD%202026%20Blog%20Featured%20Image.png</image:loc><image:caption>VRLG RDD 2026 Blog Featured Image</image:caption><image:title>VRLG RDD 2026 Blog Featured Image</image:title></image:image><lastmod>2024-09-26</lastmod></url><url><loc>https://viralgen.com/insights/digital-transformation-at-viralgen</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2025-07-31</lastmod></url><url><loc>https://viralgen.com/news/apertura-gene-therapy-and-viralgen-announce-strategic-collaboration</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gif</image:loc><image:caption>VRLG Apertura Press Release_1200x627_v1.1</image:caption><image:title>VRLG Apertura Press Release_1200x627_v1.1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><lastmod>2026-03-17</lastmod></url><url><loc>https://viralgen.com/process/aava</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/VRLG-26-007-03%20-%2001%20Foundations_Aava_1080p.mp4/medium.jpg</video:thumbnail_loc><video:title>VRLG-26-007-03 - 01 Foundations_Aava_1080p</video:title><video:description>VRLG-26-007-03 - 01 Foundations_Aava_1080p</video:description><video:content_loc>https://viralgen.com/hubfs/VRLG-26-007-03%20-%2001%20Foundations_Aava_1080p.mp4</video:content_loc><video:duration>135</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/100%25%205.svg</image:loc><image:caption>100% 5</image:caption><image:title>100% 5</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/Icons/icon_predict%201-1.png</image:loc><image:caption>icon_predict 1-1</image:caption><image:title>icon_predict 1-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/100%25.svg</image:loc><image:caption>100%</image:caption><image:title>100%</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20ASGCT%202026_post%20event%20blog_1200x627_v1.gif</image:loc><image:caption>VRLG ASGCT 2026_post event blog_1200x627_v1</image:caption><image:title>VRLG ASGCT 2026_post event blog_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/vrlg-green-play-arrow-2.svg</image:loc><image:caption>vrlg-green-play-arrow-2</image:caption><image:title>vrlg-green-play-arrow-2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_El%20Diario%20Vasco%20Sustainability%20Interview_v1.2.gif</image:loc><image:caption>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:caption><image:title>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/100%25%206.svg</image:loc><image:caption>100% 6</image:caption><image:title>100% 6</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/60%2B.svg</image:loc><image:caption>60+</image:caption><image:title>60+</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Aava-section-gem-shape.png</image:loc><image:caption>Aava-section-gem-shape</image:caption><image:title>Aava-section-gem-shape</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/Icons/icon_fast%201-1.png</image:loc><image:caption>icon_fast 1-1</image:caption><image:title>icon_fast 1-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/VRLG-Aava-website-art.svg</image:loc><image:caption>VRLG-Aava-website-art</image:caption><image:title>VRLG-Aava-website-art</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Aava_no%20tm%201.svg</image:loc><image:caption>Aava_no tm 1</image:caption><image:title>Aava_no tm 1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/AAVA%20Iturri_1%201.png</image:loc><image:caption>AAVA Iturri_1 1</image:caption><image:title>AAVA Iturri_1 1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/Icons/icon_deep%20data%201-2.png</image:loc><image:caption>icon_deep data 1-2</image:caption><image:title>icon_deep data 1-2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/AAVA-cta-section-background.png</image:loc><image:caption>AAVA-cta-section-background</image:caption><image:title>AAVA-cta-section-background</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Aava-section-shape-gen26.png</image:loc><image:caption>Aava-section-shape-gen26</image:caption><image:title>Aava-section-shape-gen26</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Aava-section-shape-3.png</image:loc><image:caption>Aava-section-shape-3</image:caption><image:title>Aava-section-shape-3</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/41.svg</image:loc><image:caption>41</image:caption><image:title>41</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Brand%20Assets/2023-2025%20Brand%20Assets/AAV%20Mendi_1-1.png</image:loc><image:caption>AAV Mendi_1-1</image:caption><image:title>AAV Mendi_1-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Aava-section-shape.png</image:loc><image:caption>Aava-section-shape</image:caption><image:title>Aava-section-shape</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_Visit%20from%20Donostia%20Mayor_v1.gif</image:loc><image:caption>VRLG blog_2026_Visit from Donostia Mayor_v1</image:caption><image:title>VRLG blog_2026_Visit from Donostia Mayor_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Triple-Plasmid%20Transfection-1.png</image:loc><image:caption>Triple-Plasmid Transfection-1</image:caption><image:title>Triple-Plasmid Transfection-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Group%20108.png</image:loc><image:caption>Group 108</image:caption><image:title>Group 108</image:title></image:image><lastmod>2026-07-22</lastmod></url><url><loc>https://viralgen.com/resources/development-of-an-analytical-method-for-aav-capsid-protein-for-use-in-stability-studies</loc><lastmod>2024-11-18</lastmod></url><url><loc>https://viralgen.com/news/viralgen-and-axovia-partner-to-manufacture-an-investigational-gene-therapy-for-retinal-dystrophy-in-bardet-biedl-syndrome-bbs-patients</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><lastmod>2025-01-22</lastmod></url><url><loc>https://viralgen.com/facilities</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/03%20-%20Downstream%20Final.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Downstream Suites</video:title><video:description>03 - Downstream Final</video:description><video:content_loc>https://viralgen.com/hubfs/03%20-%20Downstream%20Final.mp4</video:content_loc><video:duration>30</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/07%20-%20Quality%20Control%20Final.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Quality Control Labs</video:title><video:description>07 - Quality Control Final</video:description><video:content_loc>https://viralgen.com/hubfs/07%20-%20Quality%20Control%20Final.mp4</video:content_loc><video:duration>30</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/02%20-%20Upstream%20Final.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Upstream Suites</video:title><video:description>02 - Upstream Final</video:description><video:content_loc>https://viralgen.com/hubfs/02%20-%20Upstream%20Final.mp4</video:content_loc><video:duration>30</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/06%20-%20Utility%20_%20Power%20Systems%20Final.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Utility &amp;amp; Power Systems</video:title><video:description>06 - Utility _ Power Systems Final</video:description><video:content_loc>https://viralgen.com/hubfs/06%20-%20Utility%20_%20Power%20Systems%20Final.mp4</video:content_loc><video:duration>30</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/04%20-%20Fill%20&amp;%20Finish%20Final.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Fill &amp;amp; Finish</video:title><video:description>04 - Fill &amp; Finish Final</video:description><video:content_loc>https://viralgen.com/hubfs/04%20-%20Fill%20&amp;%20Finish%20Final.mp4</video:content_loc><video:duration>30</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/01%20-%20Cell%20Expansion%20Final.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Cell Expansion Suites</video:title><video:description>01 - Cell Expansion Final</video:description><video:content_loc>https://viralgen.com/hubfs/01%20-%20Cell%20Expansion%20Final.mp4</video:content_loc><video:duration>30</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/08%20-%20MSAT%20Final.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Manufacturing, Science and Technology Laboratory</video:title><video:description>08 - MSAT Final</video:description><video:content_loc>https://viralgen.com/hubfs/08%20-%20MSAT%20Final.mp4</video:content_loc><video:duration>30</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/05%20-%20Product%20Handling%20_%20Support%20Spaces%20Final.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Product Handling &amp;amp; Support Space</video:title><video:description>05 - Product Handling _ Support Spaces Final</video:description><video:content_loc>https://viralgen.com/hubfs/05%20-%20Product%20Handling%20_%20Support%20Spaces%20Final.mp4</video:content_loc><video:duration>30</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/home_1001-small%202%20(1).png</image:loc><image:caption>home_1001-small 2 (1)</image:caption><image:title>home_1001-small 2 (1)</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Facilities-gem-shape-1.png</image:loc><image:caption>Facilities-gem-shape-1</image:caption><image:title>Facilities-gem-shape-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Facilities-gen26-hero-background.png</image:loc><image:caption>Facilities-gen26-hero-background</image:caption><image:title>Facilities-gen26-hero-background</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Facilities-grid-accent-gen26.png</image:loc><image:caption>Facilities-grid-accent-gen26</image:caption><image:title>Facilities-grid-accent-gen26</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Group%2091%20(1).png</image:loc><image:caption>Group 91 (1)</image:caption><image:title>Group 91 (1)</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Facilities-image-mask-1-gen26.png</image:loc><image:caption>Facilities-image-mask-1-gen26</image:caption><image:title>Facilities-image-mask-1-gen26</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Facilities-section-shape-1.png</image:loc><image:caption>Facilities-section-shape-1</image:caption><image:title>Facilities-section-shape-1</image:title></image:image><lastmod>2026-07-29</lastmod></url><url><loc>https://viralgen.com/early-phase-production</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2026-05-19</lastmod></url><url><loc>https://viralgen.com/resources/webinar-every-day-counts</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpg</video:thumbnail_loc><video:title>Life Science Connect Webinar</video:title><video:description>Life Science Connect Webinar</video:description><video:content_loc>https://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4</video:content_loc><video:duration>2062</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gif</image:loc><image:caption>Viralgen Webinar Ane Quesada PhD</image:caption><image:title>Viralgen Webinar Ane Quesada PhD</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><lastmod>2025-12-12</lastmod></url><url><loc>https://viralgen.com/resources/pioneering-raav-characterization-with-hts-technologies</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><lastmod>2025-01-17</lastmod></url><url><loc>https://viralgen.com/expert-insights</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg</video:thumbnail_loc><video:title>10760_20251020115848541_gen_17thoct_1400et_od</video:title><video:description>10760_20251020115848541_gen_17thoct_1400et_od</video:description><video:content_loc>https://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4</video:content_loc><video:duration>3256</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpg</video:thumbnail_loc><video:title>Andy Holt @ MOTM 2025</video:title><video:description>Andy Holt @ MOTM 2025</video:description><video:content_loc>https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4</video:content_loc><video:duration>849</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpg</video:thumbnail_loc><video:title>Life Science Connect Webinar</video:title><video:description>Life Science Connect Webinar</video:description><video:content_loc>https://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4</video:content_loc><video:duration>2062</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpg</video:thumbnail_loc><video:title>Life Science In Action VIRALGEN 11_12 v3</video:title><video:description>Life Science In Action VIRALGEN 11_12 v3</video:description><video:content_loc>https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4</video:content_loc><video:duration>120</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp4/medium.jpg</video:thumbnail_loc><video:title>Viralgen Outsourced Pharma Capacity Update July 2025 - Fill/Finish</video:title><video:description>Don't miss Viralgen's presentation at Outsourced Pharma's Cell &amp;amp; Gene Therapy Capacity Update, where CCO Andy Holt unveiled an exciting initiative that will accelerate data acquisition for investor funding. Watch now us to discover how Viralgen drives industry progress through innovation and strategic support.</video:description><video:content_loc>https://viralgen.com/hubfs/2026%20Brand%20Assets/2023-2025%20Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp4</video:content_loc><video:duration>1235</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><lastmod>2026-05-19</lastmod></url><url><loc>https://viralgen.com/resources/leveraging-platform-and-process-characterization-data-to-accelerate-cgt-validation-and-commercialization</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><lastmod>2025-01-17</lastmod></url><url><loc>https://viralgen.com/insights/update-on-holistic-csr-with-viralgen-ceo-jimmy-vanhove</loc><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_El%20Diario%20Vasco%20Sustainability%20Interview_v1.2.gif</image:loc><image:caption>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:caption><image:title>VRLG blog_2026_El Diario Vasco Sustainability Interview_v1.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/El%20Dairio%20Vosca%20Sustainbility%20Interview.png</image:loc><image:caption>El Dairio Vosca Sustainbility Interview</image:caption><image:title>El Dairio Vosca Sustainbility Interview</image:title></image:image><lastmod>2026-07-27</lastmod></url><url><loc>https://viralgen.com/resources/technology-transfer-process-excellence-with-an-aav-comparability-study</loc><lastmod>2025-03-14</lastmod></url><url><loc>https://viralgen.com/resources/addressing-barriers-in-gene-therapy</loc><lastmod>2025-03-14</lastmod></url><url><loc>https://viralgen.com/resources/adding-consistency-to-gene-therapy-manufacturing</loc><lastmod>2024-10-16</lastmod></url><url><loc>https://viralgen.com/resources/enhancing-the-upstream-performance-of-adeno-associated-virus-aav-vector-manufacturing-via-multivariate-data-analysis</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><lastmod>2025-07-23</lastmod></url><url><loc>https://viralgen.com/resources</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Multivariate%20Approach%20to%20small-scale%20Model%20Qualification%20(SSMQ)%20in%20Upstream%20(USP)%20Adeno-Associated%20Virus%20(AAV)%20Production-1.png</image:loc><image:caption>Multivariate Approach to small-scale Model Qualification (SSMQ) in Upstream (USP) Adeno-Associated Virus (AAV) Production-1</image:caption><image:title>Multivariate Approach to small-scale Model Qualification (SSMQ) in Upstream (USP) Adeno-Associated Virus (AAV) Production-1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpg</image:loc><image:caption>VRLG-LSC Article_Resource_V1_LSC Article_Vial</image:caption><image:title>VRLG-LSC Article_Resource_V1_LSC Article_Vial</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gif</image:loc><image:caption>Viralgen Webinar Ane Quesada PhD</image:caption><image:title>Viralgen Webinar Ane Quesada PhD</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Screenshot%202024-09-24%20at%2010.28.29%20AM%201.png</image:loc><image:caption>Screenshot 2024-09-24 at 10.28.29 AM 1</image:caption><image:title>Screenshot 2024-09-24 at 10.28.29 AM 1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gif</image:loc><image:caption>VRLG_MotM 2025 Webinar_1200x627_v1</image:caption><image:title>VRLG_MotM 2025 Webinar_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/LSC%20Whitepaper_scientist.png</image:loc><image:caption>LSC Whitepaper_scientist</image:caption><image:title>LSC Whitepaper_scientist</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/ddPCR-Based%20Quantification%20and%20Fragment%20Analysis%20of%20Residual%20E1A%20in%20rAAV%20Products_%20Method%20Validation%20and%20Correlation%20with%20Total%20Host%20Cell%20DNA.png</image:loc><image:caption>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:caption><image:title>ddPCR-Based Quantification and Fragment Analysis of Residual E1A in rAAV Products_ Method Validation and Correlation with Total Host Cell DNA</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).png</image:loc><image:caption>VRLG GEN Webinar Oct 2025 Feature Image (1)</image:caption><image:title>VRLG GEN Webinar Oct 2025 Feature Image (1)</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><lastmod>2025-01-24</lastmod></url><url><loc>https://viralgen.com/insights/supporting-innovation-through-aav-manufacturing-a-visit-from-donostia-mayor</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRGL_Donostia_visit.jpg</image:loc><image:caption>VRGL_Donostia_visit</image:caption><image:title>VRGL_Donostia_visit</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_Visit%20from%20Donostia%20Mayor_v1.gif</image:loc><image:caption>VRLG blog_2026_Visit from Donostia Mayor_v1</image:caption><image:title>VRLG blog_2026_Visit from Donostia Mayor_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><lastmod>2026-07-16</lastmod></url><url><loc>https://viralgen.com/resources/optimizing-scale-up-of-aav-gene-therapy-in-upstream-processing</loc><lastmod>2024-10-16</lastmod></url><url><loc>https://viralgen.com/contact</loc><lastmod>2026-05-19</lastmod></url><url><loc>https://viralgen.com/resources/the-problem-of-partials-redefining-the-analytical-frameworks-surrounding-capsid-characterization</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpg</image:loc><image:caption>VRLG-LSC Article_Resource_V1_LSC Article_Vial</image:caption><image:title>VRLG-LSC Article_Resource_V1_LSC Article_Vial</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2026-05-11</lastmod></url><url><loc>https://viralgen.com/resources/benefits-of-high-throughput-sequencing-based-methods-for-in-depth-characterization-of-recombinant-aav-products</loc><video:video><video:thumbnail_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4/medium.jpg</video:thumbnail_loc><video:title>Webinar: Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:title><video:description>LSC Connect Webinar June 2, 2026 Webinar Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids</video:description><video:content_loc>https://viralgen.com/hubfs/Blog/LSC%20Connect%20Webinar%20June%202%2c%202026%20Webinar%20Addressing%20Manufacturing%20and%20Characterization%20Challenges%20and%20Opportunities%20with%20Novel%20AAV%20Capsids.mp4</video:content_loc><video:duration>3790</video:duration><video:requires_subscription>no</video:requires_subscription><video:live>no</video:live></video:video><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/Repeatability%20and%20Intermediate%20Precision%20of%20a%20Genome%20Integrity%20Assay%20for%20rAAV%20by%20Long-Read%20Sequencing.png</image:loc><image:caption>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:caption><image:title>Repeatability and Intermediate Precision of a Genome Integrity Assay for rAAV by Long-Read Sequencing</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20LSC%20Webinar%20Thumbnail.png</image:loc><image:caption>VRLG LSC Webinar Thumbnail</image:caption><image:title>VRLG LSC Webinar Thumbnail</image:title></image:image><lastmod>2025-07-23</lastmod></url><url><loc>https://viralgen.com/news/askbios-viralgen-to-supply-commercial-scale-drug-product-for-regenerate</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%202026%20AskBio%20ASGCT%20Press%20Release_1200x627_v1.gif</image:loc><image:caption>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:caption><image:title>VRLG 2026 AskBio ASGCT Press Release_1200x627_v1</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/AskBios%20Viralgen%20to%20Supply%20Commercial-Scale%20Drug%20Product%20for%20REGENERATE-PD%20Investigational%20Gene%20Therapy%20Phase%20II%20Trial%20for%20Parkinson%E2%80%99s%20Disease.gif</image:loc><image:caption>AskBios Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease</image:caption><image:title>AskBios Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2026-04-20</lastmod></url><url><loc>https://viralgen.com/news/visit-of-lehendakari-imanol-pradales-and-his-team-to-viralgen-facilities</loc><image:image><image:loc>https://viralgen.com/hubfs/Blog/Blog%20FI_From%20Platform%20Promise%20to%20Commercial%20Reality.png</image:loc><image:caption>Blog FI_From Platform Promise to Commercial Reality</image:caption><image:title>Blog FI_From Platform Promise to Commercial Reality</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/VRLG%20PR_2026_EpilepsyGTx_v2.png</image:loc><image:caption>VRLG PR_2026_EpilepsyGTx_v2</image:caption><image:title>VRLG PR_2026_EpilepsyGTx_v2</image:title></image:image><image:image><image:loc>https://viralgen.com/hubfs/Blog/VRLG%20blog_2026_ARPA-H%20Thrive%20Award_v2.2.gif</image:loc><image:caption>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:caption><image:title>VRLG blog_2026_ARPA-H Thrive Award_v2.2</image:title></image:image><lastmod>2024-11-22</lastmod></url></urlset>